Arrow Therapeutics Ltd. Selects Hepatitis C Clinical Candidate
LONDON, Feb. 6 /CNW/ - Arrow Therapeutics, the London based antiviral
drug discovery and development company, has announced that its lead
Hepatitis C compound has entered full preclinical development.